Formulation and Characterisation of Herbal Ethosomal Gel of Luliconazole and Clove Oil for Modified Drug Diffusion to the Skin

Bhanu Pratap; Shamim Khan; Shadab Ali

doi:10.52711/0974-360X.2025.00504

Research Journal of Pharmacy and Technology

ISSN

0974-360X (Online)
0974-3618 (Print)

Submit Article

Formulation and Characterisation of Herbal Ethosomal Gel of Luliconazole and Clove Oil for Modified Drug Diffusion to the Skin

Author(s): Bhanu Pratap, Shamim Khan, Shadab Ali

Email(s): bhanuluci666@gmail.com

DOI: 10.52711/0974-360X.2025.00504

Address: Bhanu Pratap*, Shamim Khan, Shadab Ali
Department of Pharmacy, IIMT College of Medical Science, IIMT University, Ganga Nagar, Meerut - 250001, Uttar Pradesh, India.
*Corresponding Author

Published In: Volume - 18, Issue - 8, Year - 2025

View HTML

Purchase PDF

ABSTRACT:
The creation, characterisation, and optimisation of an herbal ethosomal formulation are all included in this work. The current study aims to create ethosomes filled with drugs and capped with Syzygium Aromaticum L., or clove oil. These ethosomes are then further mixed into Carbopol 934 K, which forms an ethosomal gel. The formulation aims to convey a fungal infection treatment that is successful. The medication (luliconazole), soy lecithin, clove extract, and propylene glycol were used in the formulation of the construct. Six ethosomal formulations with different constituent concentrations were processed in total to identify the best formulation out of the bunch. In addition, a number of assessment criteria, including the percent of entrapment efficiency, the size of the particle, zeta potential, and polydispersity index (PDI), were used to the generated drug-loaded ethosomes. By utilising transmission electron microscopy, the surface morphology was evaluated, while atomic force microscopy was used to get further in-depth information about the surface morphology. In order to study thermal behaviour for luliconazole, soya lecithin, clove extract, physical mixture, and optimised formulation (EF5), a thermal gravimetric analysis graph was produced. The ethosomal gel's viscosity, pH, Spreadability, and extrudability were calculated to assess the formulation's appropriateness for topical application. The entire study concludes that luliconazole can be delivered in an advanced, targeted, and sustained manner using this herbal ethosomal method. Because of its ideal soy lecithin dosage of 400mg and ethanol concentration of 30%, After analysis of the data, the ethosomal formulation EF5 was found to be the most optimal one. This results in a maximum entrapment efficiency of 88.56±0.74%. It was found that the optimal PDI, zeta potential, and vesicle size were 0.186±0.07, - 42.2±0.3mV, and 155.3±1.2nm, respectively. The best stable solutions were found to be ethosomal suspension and lyophilized ethosomal suspension at 4°C/60 ±5 RH. The whole study demonstrates that the combination of ethosomal formulation with luliconazole and clove extract has a synergistic effect and works well to treat fungal infection.

Keywords:

Cite this article:
Bhanu Pratap, Shamim Khan, Shadab Ali. Formulation and Characterisation of Herbal Ethosomal Gel of Luliconazole and Clove Oil for Modified Drug Diffusion to the Skin. Research Journal Pharmacy and Technology. 2025;18(8):3501-8. doi: 10.52711/0974-360X.2025.00504

Cite(Electronic):
Bhanu Pratap, Shamim Khan, Shadab Ali. Formulation and Characterisation of Herbal Ethosomal Gel of Luliconazole and Clove Oil for Modified Drug Diffusion to the Skin. Research Journal Pharmacy and Technology. 2025;18(8):3501-8. doi: 10.52711/0974-360X.2025.00504 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2025-18-8-7

REFERENCES:
1. Ainbinder D, Touitou E. Testosterone ethosomes for enhanced transdermal delivery. Drug Deliv. 2010; 12:297–303.doi: 10.1080/10717540500176910.
2. Ainbinder D, Protok in R, Chaouat M, Touitou E. Effect of honokiol and 5-FU on non-melanoma skin cancer cells. J Drug Deliv SciTech Nol. 2009; 19: 283–287. doi: 10.1016/S1773-2247(09)50053-6.
3. Shumilov M, Touitou E. Buspirone transdermal administration for menopausal syndromes, in vitro and in animal model studies.Int J Pharm. 2010; 387: 26–33. doi: 10.1016/j.ijpharm.2009.11.029.
4. Shumilov M, Bercovich R, Duchi S, Ainbinder D, Touitou E. Ibuprofen transdermal ethosomal gel: characterization and efficiencyin animal models. J Biomed Nanotechnol. 2010; 6: 569–576. doi: 10.1166/jbn.2010.1153.
5. Nethravathi V, Vijaitha V. Effectiveness of Clove oil massage on Lower Back Pain among Post Natal Mothers at Selected Hospitals, Bangalore. Asian J. Nur. Edu. and Research. 2015; 5(4): 467-470.
6. Design, Formulation and in vitro Drug Release from Transdermal Patches containing Nebivolol Hydrochloride as Model Drug. Asian J. Pharm. Res. 2012; 2(4): 136-141.
7. R. S. Kalkotwar, R. B. Saudagar. Design, Synthesis and anti-microbial, anti-inflammatory, Antitubercular activities of some 2,4,5-trisubstituted imidazole derivatives. Asian J. Pharm. Res. 2013; 3(4): 159-165.
8. Rutuja R. Shah, Rohan R. Vakhariya. Formulation and Evaluation of Antifungal Soap of Garlic Oil. Asian J. Pharm. Res. 2020; 10(1):13-16.
9. Pallavi U. Jadhav, Sandhya G. Gujare, Mulchand A. Shende. Ethosomes: A Novel Tool for Vesicular Drug Delivery. Asian Journal of Pharmaceutical Research. 2024; 14(1): 45-2.
10. Prashant S. Wake, M. D. Kshirsagar. Design and Characterization of Solid Lipid Nanoparticle Based Transdermal Drug Delivery System. Asian J. Res. Pharm. Sci. 2017; 7(2): 87-91.
11. Cappelletty D, Eiselstein-McKitrick K. The echinocandins. Pharmacotherapy. 2007; 27: 369–388. doi: 10.1592/phco.27.3.369.
12. Sutton CL, Taylor ZE, Farone MB, Handy ST. Antifungal activity of substituted aurones. Bioorg Med Chem Lett. 2017; 27: 901–903.doi: 10.1016/j.bmcl.2017.01.012.
13. Sheehan DJ, Hitchcock CA, Sibley CM. Current and emerging azole antifungal agents. Clin Microbiol Rev. 1999; 12: 40–79.doi: 10.1128/CMR.12.1.40.
14. Baginski M, Czub J. Amphotericin B and its new derivatives—mode of action. Curr Drug Metab. 2009; 10: 459–469.doi: 10.2174/138920009788898019.
15. Y. Sirisha, Buddarthi Sriram, Ramya Sri S. Formulation Development and Evaluation Nefidipine Loaded Ethosomal Gel for Transdermal Drug Delivery. Asian Journal of Pharmaceutical Research. 2023; 13(2): 77-0.
16. Pandey G, Verma KK, Singh M. Evaluation of phytochemical, antibacterial and free radical scavenging properties of Azadirachtaindica (neem) leaves. Int J Pharm Pharm Sci. 2014; 6(2): 444–447.
17. Rutuja R Shah, Poonam J Patil, Pratibha R Adnaik, Rahul S Adnaik. Biochemical profiling of Antifungal soap activity of betel leaf (Piper betle L.) extract and Garlic oil by In vitro method. Asian J. Pharm. Res. 2020; 10(4): 260-262.
18. Muskan M. Maniyar, Amol S. Deshmukh, Suvarna J. Shelke. Ethosomes: A carrier for Transdermal Drug Delivery System. Asian Journal of Pharmaceutical Research. 2022; 12(3): 225-8.
19. Touitou E, Dayana N, Bergelsonb L, Godina B, Eliaza M. Ethosomes-novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release. 2000; 65: 403–418. doi: 10.1016/S0168-3659(99)00222-9.
20. Dave V, Sharma S, Yadav RB, Agarwal U. Herbal liposome for the topical delivery of ketoconazole for the effective treatment ofseborrheic dermatitis. Appl Nanosci. 2017; 7: 973–987. doi: 10.1007/s13204-017-0634-3.
21. Anand N, Johnson M, Arulsamy A. Antifungal properties of neem (Azadirachta indica) leaves extract to treatment hair dandruff. E-Int Sci Res J. 2010; 2: 244–252.
22. Paliwal S, Tilaka A, Sharma J, Dave V, Sharma S, Verma K, Tak K, Raghava K, Veera SR. Flurbiprofen-loaded ethanolic liposomeparticles for biomedical applications. J Microbiol. 2019; 161: 18–27.
23. Ch. Nagadev, M. Durga Srinivasa Rao, P. Venkatesh, D. Hepcykalarani, R. Prema. A Review on Transdermal Drug Delivery Systems. Asian J. Res. Pharm. Sci. 2020; 10(2):109-114.
24. Paliwal S, Tilaka A, Sharma J, Dave V, Sharma S, Verma K, Tak K, Raghava K, Veera SR. Flurbiprofen-loaded ethanolic liposomeparticles for biomedical applications. J Microbiol. 2019; 161: 18–27.
25. Paliwal S, Tilak A, Sharma J, Dave V, Sharma S, Yadav RB, Patel S, Verma K, Tak K. Flurbiprofen loaded ethosomes-transdermaldelivery of anti-inflammatory effect in rat model. Lipids Health Dis. 2019; 18: 1–15. doi: 10.1186/s12944-019-1064-x.
26. Pathana IB, Jawarea BP, Shelkeb S, Ambekarc W. Curcumin loaded ethosomes for transdermal application: formulation,optimization, in-vitro and in-vivo study. J Drug Deliv Sci Technol. 2017; 44: 49–57. doi: 10.1016/j.jddst.2017.11.005.
27. Dave V, Yadav RB, Kushwaha K. Hybrid nanoparticles for the topical delivery of norfloxacin for the effective treatment of bacterialinfection produced after burn. J Microencapsul. 2017; 21: 67–77.
28. Ling G, Zhang P, Zhang W, Sun J, Meng Z, Qin Y, Deng Y, He Z. Development of novel self-assembled DS-PLGA hybrid nanoparticles for improving oral bioavailability of vincristine sulphate by P-gp inhibition. J Control Release. 2010; 148: 241–248.doi: 10.1016/j.jconrel.2010.08.010.
29. Shah PP, Desai PR, Singh M. Effect of oleic acid modified polymeric bilayered nanoparticles on percutaneous delivery of spantideII and ketoprofen. J Control Release. 2012; 158: 336–345. doi: 10.1016/j.jconrel.2011.11.016.
30. Mandal B, Bhattacharjee H, Mittal SH, Balabathula P, Thoma LA, Wood GC. Core-shell type lipid-polymer hybrid nanoparticles as adrug delivery platform. Nanomed Nanotechnol Biol Med. 2013; 9: 474–491. doi: 10.1016/j.nano.2012.11.010.
31. Panigrahi L, Ghosal SK, Pattnaik S, Maharana L, Barik BB. Effect of permeation enhancers on the release and permeation kineticsof lincomycin hydrochloride gel formulations though mouse skin. Indian J Pharm Sci. 2006; 68: 205–211. doi: 10.4103/0250-474X.25716.
32. Kim HS, Song IH, Kim JC. In vitro and in vivo gene transferring characteristics of novel cationic lipids, DMKD (O,O 0-dimyristyl-N-lysyl aspartate) and DMKE (O, O0-dimyristyl-N-lysylglutamate) J Control Release. 2006; 11: 234–241.doi: 10.1016/j.jconrel.2006.08.003.
33. Verma DD, Verma S, Blume G, Fah A. Size of particle of liposomes influences dermal delivery of substances into skin. Int J Pharm.2003; 258: 141–151. doi: 10.1016/S0378-5173(03)00183-2.
34. Plessis JD, Ramachandran C, Weiner N, Müller DG. The influence of size of particle of liposomes on the deposition of drug into skin.Int J Pharm. 1994; 103: 277–282. doi: 10.1016/0378-5173(94)90178-3.
35. Bratu I, Borodi G, Kacso I, Moldovana Z, Filip C, Dragan F, Vasilescu M, Simon S. New solid form of Norfloxacin: structuralstudies. J Spectrosc. 2011; 25: 53–62. doi: 10.1155/2011/462913.
36. Muller RH, Radtke M, Wissing SA. Solid lipid nanoparticles and nanostructured lipid carriers in cosmetics and dermatological preparations. Adv Drug Deliv Rev. 2002; 54: 131–155. doi: 10.1016/S0169-409X(02)00118-7.
37. Dave V, Sharma S, Yadav RB, Agarwal U. Herbal liposome for the topical delivery of ketoconazole for the effective treatment of seborrheic dermatitis. Appl Nanosci. 2017; 7: 973–987. doi: 10.1007/s13204-017-0634-3.
38. Panigrahi L, Ghosal SK, Pattnaik S, Maharana L, Barik BB. Effect of permeation enhancers on the release and permeation kinetics of lincomycin hydrochloride gel formulations though mouse skin. Indian J Pharm Sci. 2006; 68: 205–211. doi: 10.4103/0250-474X.25716.
39. Shumilov M, Touitou E. Buspirone transdermal administration for menopausal syndromes, in vitro and in animal model studies.Int J Pharm. 2010; 387: 26–33. doi: 10.1016/j.ijpharm.2009.11.029.
40. Sutton CL, Taylor ZE, Farone MB, Handy ST. Antifungal activity of substituted aurones. Bioorg Med Chem Lett. 2017; 27: 901–903.doi: 10.1016/j.bmcl.2017.01.012.
41. Verma DD, Verma S, Blume G, Fah A. Size of particle of liposomes influences dermal delivery of substances into skin. Int J Pharm.2003; 258:141–151. doi: 10.1016/S0378-5173(03)00183-2.
42. Ling G, Zhang P, Zhang W, Sun J, Meng Z, Qin Y, Deng Y, He Z. Development of novel self-assembled DS-PLGA hybrid nanoparticles for improving oral bioavailability of vincristine sulphate by P-gp inhibition. J Control Release. 2010; 148:241–248.doi: 10.1016/j.jconrel.2010.08.010.
43. Shah PP, Desai PR, Singh M. Effect of oleic acid modified polymeric bilayered nanoparticles on percutaneous delivery of spantide II and ketoprofen. J Control Release. 2012; 158: 336–345. doi: 10.1016/j.jconrel.2011.11.016.
44. Kim HS, Song IH, Kim JC. In vitro and in vivo gene transferring characteristics of novel cationic lipids, DMKD (O, O 0-dimyristyl-N-lysyl aspartate) and DMKE (O, O0-dimyristyl-N-lysylglutamate) J Control Release. 2006; 11: 234–241.doi: 10.1016/j.jconrel.2006.08.003.